Glenn Kazo

Company: ARIZ Precision Medicines

Job title: Chief Business Officer

Seminars:

A Ligand-targeted Calcium-phosphate Drug Delivery System for Cancer 2:45 pm

Alternatives to traditional RNAi delivery approaches are needed for cancer targets ARIZ’s preclinical novel siRNA formulated in a calcium-phosphate drug delivery system with a tumor targeting ligand, targets a histone methyltransferase that is one of the earliest changes in cancerization of the cell Proof of concept with our ligand targeted calcium-phosphate siRNA-conjugate delivery platform broadly…Read more

day: Conference Day Two

Seizing the Value of RNAi Therapeutics for Oncology to Develop Precise, Effective Treatments for Patients 2:00 pm

RNAi therapeutics holds promise for treating complex genetic diseases such as cancer by targeting multiple oncogenes, but release of the therapeutic payload must be rapid and precise, and the heterogeneity of tumors must be considered. Therefore, this Workshop will address: How to identify genetic targets in heterogenous tumors to increase correlation in response at the…Read more

day: Pre-Conference Workshop Day